4D Molecular Therapeutics, Inc.FDMTNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+29.3%
5Y CAGR+28.3%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+29.3%/yr
vs +46.6%/yr prior
5Y CAGR
+28.3%/yr
Consistent
Acceleration
-17.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.5x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$244.76M+30.3%
2024$187.88M+40.6%
2023$133.59M+18.1%
2022$113.16M+26.6%
2021$89.37M+27.2%
2020$70.28M+21.7%
2019$57.75M+135.4%
2018$24.53M+43.8%
2017$17.06M-